Global and United States Leber Congenital Amaurosis (LCA) Market Report & Forecast 2023-2028

Report ID: 1873376 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Leber Congenital Amaurosis (LCA) Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Leber Congenital Amaurosis (LCA) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Leber Congenital Amaurosis (LCA) Market Size for the Year 2017-2028
        1.2.2 Global Leber Congenital Amaurosis (LCA) Market Size for the Year 2017-2028
    1.3 Leber Congenital Amaurosis (LCA) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Leber Congenital Amaurosis (LCA) in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Leber Congenital Amaurosis (LCA) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Leber Congenital Amaurosis (LCA) Market Dynamics
        1.4.1 Leber Congenital Amaurosis (LCA) Industry Trends
        1.4.2 Leber Congenital Amaurosis (LCA) Market Drivers
        1.4.3 Leber Congenital Amaurosis (LCA) Market Challenges
        1.4.4 Leber Congenital Amaurosis (LCA) Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Leber Congenital Amaurosis (LCA) by Type
    2.1 Leber Congenital Amaurosis (LCA) Market Segment by Type
        2.1.1 Infantile Type
        2.1.2 Juvenile Type
    2.2 Global Leber Congenital Amaurosis (LCA) Market Size by Type (2017, 2022 & 2028)
    2.3 Global Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2028)
    2.4 United States Leber Congenital Amaurosis (LCA) Market Size by Type (2017, 2022 & 2028)
    2.5 United States Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2028)
3 Leber Congenital Amaurosis (LCA) by Application
    3.1 Leber Congenital Amaurosis (LCA) Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Eye Clinics
        3.1.3 Medical Research Institute
        3.1.4 Other
    3.2 Global Leber Congenital Amaurosis (LCA) Market Size by Application (2017, 2022 & 2028)
    3.3 Global Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2028)
    3.4 United States Leber Congenital Amaurosis (LCA) Market Size by Application (2017, 2022 & 2028)
    3.5 United States Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2028)
4 Global Leber Congenital Amaurosis (LCA) Competitor Landscape by Company
    4.1 Global Leber Congenital Amaurosis (LCA) Market Size by Company
        4.1.1 Top Global Leber Congenital Amaurosis (LCA) Companies Ranked by Revenue (2021)
        4.1.2 Global Leber Congenital Amaurosis (LCA) Revenue by Player (2017-2022)
    4.2 Global Leber Congenital Amaurosis (LCA) Concentration Ratio (CR)
        4.2.1 Leber Congenital Amaurosis (LCA) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Leber Congenital Amaurosis (LCA) in 2021
        4.2.3 Global Leber Congenital Amaurosis (LCA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Leber Congenital Amaurosis (LCA) Headquarters, Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Leber Congenital Amaurosis (LCA) Headquarters and Area Served
        4.3.2 Global Leber Congenital Amaurosis (LCA) Companies Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Leber Congenital Amaurosis (LCA) Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Leber Congenital Amaurosis (LCA) Market Size by Company
        4.5.1 Top Leber Congenital Amaurosis (LCA) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Leber Congenital Amaurosis (LCA) Revenue by Players (2020, 2021 & 2022)
5 Global Leber Congenital Amaurosis (LCA) Market Size by Region
    5.1 Global Leber Congenital Amaurosis (LCA) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Leber Congenital Amaurosis (LCA) Market Size by Region (2017-2028)
        5.2.1 Global Leber Congenital Amaurosis (LCA) Market Size by Region: 2017-2022
        5.2.2 Global Leber Congenital Amaurosis (LCA) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Leber Congenital Amaurosis (LCA) Market Size YoY Growth 2017-2028
        6.1.2 North America Leber Congenital Amaurosis (LCA) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Leber Congenital Amaurosis (LCA) Market Size YoY Growth 2017-2028
        6.3.2 Europe Leber Congenital Amaurosis (LCA) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Leber Congenital Amaurosis (LCA) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Leber Congenital Amaurosis (LCA) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Leber Congenital Amaurosis (LCA) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Leber Congenital Amaurosis (LCA) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AmpliPhi Biosciences
        7.1.1 AmpliPhi Biosciences Company Details
        7.1.2 AmpliPhi Biosciences Business Overview
        7.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Introduction
        7.1.4 AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022)
        7.1.5 AmpliPhi Biosciences Recent Development
    7.2 Editas Medicine
        7.2.1 Editas Medicine Company Details
        7.2.2 Editas Medicine Business Overview
        7.2.3 Editas Medicine Leber Congenital Amaurosis (LCA) Introduction
        7.2.4 Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022)
        7.2.5 Editas Medicine Recent Development
    7.3 Novelion Therapeutics
        7.3.1 Novelion Therapeutics Company Details
        7.3.2 Novelion Therapeutics Business Overview
        7.3.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Introduction
        7.3.4 Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022)
        7.3.5 Novelion Therapeutics Recent Development
    7.4 ProQR Therapeutics
        7.4.1 ProQR Therapeutics Company Details
        7.4.2 ProQR Therapeutics Business Overview
        7.4.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Introduction
        7.4.4 ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022)
        7.4.5 ProQR Therapeutics Recent Development
    7.5 Spark Therapeutics
        7.5.1 Spark Therapeutics Company Details
        7.5.2 Spark Therapeutics Business Overview
        7.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Introduction
        7.5.4 Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022)
        7.5.5 Spark Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Leber Congenital Amaurosis (LCA) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Leber Congenital Amaurosis (LCA) Market Trends
    Table 3. Leber Congenital Amaurosis (LCA) Market Drivers
    Table 4. Leber Congenital Amaurosis (LCA) Market Challenges
    Table 5. Leber Congenital Amaurosis (LCA) Market Restraints
    Table 6. Global Leber Congenital Amaurosis (LCA) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Leber Congenital Amaurosis (LCA) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Leber Congenital Amaurosis (LCA) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Leber Congenital Amaurosis (LCA) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Leber Congenital Amaurosis (LCA) Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Leber Congenital Amaurosis (LCA) Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Leber Congenital Amaurosis (LCA) Revenue Share by Player, 2017-2022
    Table 13. Global Leber Congenital Amaurosis (LCA) Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Leber Congenital Amaurosis (LCA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber Congenital Amaurosis (LCA) as of 2021)
    Table 15. Top Players of Leber Congenital Amaurosis (LCA) in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Leber Congenital Amaurosis (LCA) Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Leber Congenital Amaurosis (LCA) Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Leber Congenital Amaurosis (LCA) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Leber Congenital Amaurosis (LCA) Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Leber Congenital Amaurosis (LCA) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Leber Congenital Amaurosis (LCA) Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Leber Congenital Amaurosis (LCA) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Leber Congenital Amaurosis (LCA) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Leber Congenital Amaurosis (LCA) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Leber Congenital Amaurosis (LCA) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Leber Congenital Amaurosis (LCA) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AmpliPhi Biosciences Company Details
    Table 31. AmpliPhi Biosciences Business Overview
    Table 32. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product
    Table 33. AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million)
    Table 34. AmpliPhi Biosciences Recent Development
    Table 35. Editas Medicine Company Details
    Table 36. Editas Medicine Business Overview
    Table 37. Editas Medicine Leber Congenital Amaurosis (LCA) Product
    Table 38. Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million)
    Table 39. Editas Medicine Recent Development
    Table 40. Novelion Therapeutics Company Details
    Table 41. Novelion Therapeutics Business Overview
    Table 42. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product
    Table 43. Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million)
    Table 44. Novelion Therapeutics Recent Development
    Table 45. ProQR Therapeutics Company Details
    Table 46. ProQR Therapeutics Business Overview
    Table 47. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product
    Table 48. ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million)
    Table 49. ProQR Therapeutics Recent Development
    Table 50. Spark Therapeutics Company Details
    Table 51. Spark Therapeutics Business Overview
    Table 52. Spark Therapeutics Leber Congenital Amaurosis (LCA) Product
    Table 53. Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2017-2022) & (US$ Million)
    Table 54. Spark Therapeutics Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Leber Congenital Amaurosis (LCA) Product Picture
    Figure 2. Global Leber Congenital Amaurosis (LCA) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Leber Congenital Amaurosis (LCA) Market Size 2017-2028 (US$ Million)
    Figure 4. United States Leber Congenital Amaurosis (LCA) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Leber Congenital Amaurosis (LCA) Market Size 2017-2028 (US$ Million)
    Figure 6. United States Leber Congenital Amaurosis (LCA) Market Share in Global 2017-2028
    Figure 7. Leber Congenital Amaurosis (LCA) Report Years Considered
    Figure 8. Product Picture of Infantile Type
    Figure 9. Product Picture of Juvenile Type
    Figure 10. Global Leber Congenital Amaurosis (LCA) Market Share by Type in 2022 & 2028
    Figure 11. Global Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Leber Congenital Amaurosis (LCA) Market Share by Type (2017-2028)
    Figure 13. United States Leber Congenital Amaurosis (LCA) Market Share by Type in 2022 & 2028
    Figure 14. United States Leber Congenital Amaurosis (LCA) Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Leber Congenital Amaurosis (LCA) Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Eye Clinics
    Figure 18. Product Picture of Medical Research Institute
    Figure 19. Product Picture of Other
    Figure 20. Global Leber Congenital Amaurosis (LCA) Market Share by Application in 2022 & 2028
    Figure 21. Global Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Leber Congenital Amaurosis (LCA) Market Share by Application (2017-2028)
    Figure 23. United States Leber Congenital Amaurosis (LCA) Market Share by Application in 2022 & 2028
    Figure 24. United States Leber Congenital Amaurosis (LCA) Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Leber Congenital Amaurosis (LCA) Market Share by Application (2017-2028)
    Figure 26. North America Leber Congenital Amaurosis (LCA) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Leber Congenital Amaurosis (LCA) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Leber Congenital Amaurosis (LCA) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. AmpliPhi Biosciences Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2017-2022)
    Figure 55. Editas Medicine Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2017-2022)
    Figure 56. Novelion Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2017-2022)
    Figure 57. ProQR Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2017-2022)
    Figure 58. Spark Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AmpliPhi Biosciences
Editas Medicine
Novelion Therapeutics
ProQR Therapeutics
Spark Therapeutics
Frequently Asked Questions
Leber Congenital Amaurosis (LCA) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leber Congenital Amaurosis (LCA) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leber Congenital Amaurosis (LCA) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports